Breaking News

Kindeva Drug Delivery Receives £33M U.K. Government Grant

Supports global development and manufacturing of the next generation of green pressurized metered-dose inhalers.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Kindeva Drug Delivery, a global drug delivery device CDMO, received a £33 million grant from the U.K. Government’s Life Sciences Innovation Manufacturing Fund (LSIMF) toward enhancing inhaler manufacturing and sustainability. The joint funds aim to enhance Kindeva’s capability and capacity to manufacture the next generation of green pressurized metered-dose inhalers (pMDIs) and to continue delivering evolving therapies for respiratory diseases. The investment supports global development and m...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters